# ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer

> **NCT03294889** · PHASE1,PHASE2 · RECRUITING · sponsor: **University Hospital, Geneva** · enrollment: 45 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Stereotactic body radition (SBRT)

## Key facts

- **NCT ID:** NCT03294889
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-09-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2020-05-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03294889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03294889, "ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03294889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*